Patent Application
Provisional
App. No. 63/525,265
· Confirmation No. 9098
ORAL DOSAGE FORMS AND ORAL DOSING REGIMENS FOR TREATMENT OF COMPLEMENT MEDIATED DISEASES
Applicant:
BioCryst Pharmaceuticals, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2023-07-18 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2023-07-06 | TR.PROV |
Provisional Cover Sheet (SB16) | 2 | View | |
| 2023-07-06 | ADS |
Application Data Sheet | 5 | View | |
| 2023-07-06 | SPEC |
Specification | 28 | View | |
| 2023-07-06 | CLM |
Claims | 5 | View | |
| 2023-07-06 | ABST |
Abstract | 1 | View | |
| 2023-07-06 | DRW.NONBW |
Drawings-other than black and white line drawings | 17 | View | |
| 2023-07-06 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2023-07-06 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2023-07-06 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View | |
| 2023-07-06 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View |
Inventors
Attorneys & Agents of Record
Prosecution
- Customer No.
- 25181
- Docket No.
- BPX-05462
- Confirmation No.
- 9098
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/525,265
- Filed
- 2023-07-06
External Links